Literature DB >> 28193057

Development of APTES-Decorated HepG2 Cancer Stem Cell Membrane Chromatography for Screening Active Components from Salvia miltiorrhiza.

Xuan Ding1, Yan Cao1, Yongfang Yuan2, Zhirong Gong1, Yue Liu1, Liang Zhao3, Lei Lv3, Guoqing Zhang3, Dongyao Wang1, Dan Jia1, Zhenyu Zhu1, Zhanying Hong1, Xiaofei Chen1, Yifeng Chai1.   

Abstract

Cell membrane chromatography (CMC) is an ideal method for screening potential active components acting on target cell membranes from a complex system, such as herbal medicines. But due to the decay and falling-off of membranes, the CMC column suffers from short life span and low reproducibility. This has greatly limited the application of this model, especially when the cell materials are hard to obtain. To solve this problem, a novel type of (3-aminopropyl)triethoxysilane (APTES)-decorated silica gel was employed. The silica gel was decorated with aldehydes with the help of APTES, which react with the amino groups on cell membranes to form a covalent bond. In this way, cell membranes were immobilized on the surface of silica gel, so it is not easy for membranes to fall off. According to our investigation, the column life of the APTES-decorated group was prolonged to more than 12 days, while the control group showed a sharp decline in column efficiency in the first 3 days. To verify this model, a novel APTES-decorated HepG2 cancer stem cell membrane chromatography (CSCMC) was established and applied in a comprehensive two-dimensional chromatographic system to screen potential active components in Salvia miltiorrhiza. As a result, tanshinone IIA, cryptotanshinone, and dihydrotanshinone I were retained on this model and proved to be effective on HepG2 cancer stem cells by the following cell proliferation and apoptosis assay, with IC50 of 10.30 μM, 17.85 μM, and 2.53 μM, respectively. This improvement of CMC can significantly prolong its column life span and broaden the range of its application, which is very suitable for making invaluable or hard-to-obtain cell materials, such as stem cells, for specific drug screening.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28193057     DOI: 10.1021/acs.analchem.6b02709

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  9 in total

1.  Targeting actin-bundling protein L-plastin as an anabolic therapy for bone loss.

Authors:  Xiaoqun Li; Lipeng Wang; Biaotong Huang; Yanqiu Gu; Ying Luo; Xin Zhi; Yan Hu; Hao Zhang; Zhengrong Gu; Jin Cui; Liehu Cao; Jiawei Guo; Yajun Wang; Qirong Zhou; Hao Jiang; Chao Fang; Weizong Weng; Xiaofei Chen; Xiao Chen; Jiacan Su
Journal:  Sci Adv       Date:  2020-11-18       Impact factor: 14.136

Review 2.  Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science.

Authors:  Yuening Xiang; Zimu Guo; Pengfei Zhu; Jia Chen; Yongye Huang
Journal:  Cancer Med       Date:  2019-04-03       Impact factor: 4.452

3.  Accurate construction of cell membrane biomimetic graphene nanodecoys via purposeful surface engineering to improve screening efficiency of active components of traditional Chinese medicine.

Authors:  Qi Hu; Lanlan Jia; Xiaolin Zhang; Aihong Zhu; Sicen Wang; Xiaoyu Xie
Journal:  Acta Pharm Sin B       Date:  2021-05-26       Impact factor: 11.413

Review 4.  Novel perspectives on the therapeutic role of cryptotanshinone in the management of stem cell behaviors for high-incidence diseases.

Authors:  Xiaomeng Guo; Ruishuang Ma; Meng Wang; Benson Wui-Man Lau; Xiaopeng Chen; Yue Li
Journal:  Front Pharmacol       Date:  2022-08-15       Impact factor: 5.988

5.  I n situ synthesis and unidirectional insertion of membrane proteins in liposome-immobilized silica stationary phase for rapid preparation of microaffinity chromatography.

Authors:  Yanqiu Gu; Rong Wang; Panpan Chen; Shengnan Li; Xinyi Chai; Chun Chen; Yue Liu; Yan Cao; Diya Lv; Zhanying Hong; Zhenyu Zhu; Yifeng Chai; Yongfang Yuan; Xiaofei Chen
Journal:  Acta Pharm Sin B       Date:  2022-04-22       Impact factor: 14.903

6.  Cryptotanshinone Inhibits the Growth of HCT116 Colorectal Cancer Cells Through Endoplasmic Reticulum Stress-Mediated Autophagy.

Authors:  Xiaojing Fu; Wenwen Zhao; Kangkang Li; Jingyi Zhou; Xuehong Chen
Journal:  Front Pharmacol       Date:  2021-06-17       Impact factor: 5.810

7.  Clinical verification of vimentin/EpCAM immunolipid magnetic sorting system in monitoring CTCs in arterial and venous blood of advanced tumor.

Authors:  Yan Liu; Qiuying Li; Tingsong Chen; Tianhao Shen; Xufeng Zhang; Ping Song; Lantao Liu; Jianming Liu; Tinghui Jiang; Xiaofei Liang
Journal:  J Nanobiotechnology       Date:  2021-06-16       Impact factor: 10.435

8.  Cell Chromatography-Based Screening of the Active Components in Buyang Huanwu Decoction Promoting Axonal Regeneration.

Authors:  Xiangli Yan; Shengxin Wang; Aiming Yu; Xiao Shen; Haozhen Zheng; Lisheng Wang
Journal:  Biomed Res Int       Date:  2019-09-29       Impact factor: 3.411

9.  Comprehensive two-dimensional APTES-decorated MCF7-cell membrane chromatographic system for characterizing potential anti-breast-cancer components from Yuanhu-Baizhi herbal medicine pair.

Authors:  Xiao-Yu Wang; Xuan Ding; Yong-Fang Yuan; Le-Yi Zheng; Yan Cao; Zhen-Yu Zhu; Guo-Qing Zhang; Yi-Feng Chai; Xiao-Fei Chen; Zhan-Ying Hong
Journal:  J Food Drug Anal       Date:  2017-12-19       Impact factor: 6.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.